Nervgen Pharma NGEN
NASDAQ NGEN
$1.52 -0.02 (-1.30%)
As of: Oct 21, 2026 · 2:44 PM EDT

Nervgen Pharma (NGEN) Receivables (2024 - 2026)

Updated

Nervgen Pharma's Receivables came in at $144,756 for the quarter ended Jun 30, 2026, up 112.2% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Receivables (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma's Receivables was $57,848, down 80.9% from the prior year.

  • Going back by year, Receivables was $303,336 in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Receivables since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 13.82 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 12.49 Bn
10 Nervgen Pharma 109.94 Mn 8.82 Mn - 140,921.95
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140,921.95
Mar 31, 2026 67,154.64
Dec 31, 2025 65,130.30
Dec 31, 2024 295,244.52
API Access

Nervgen Pharma Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NGEN&period=max&api_key=YOUR_API_KEY